We are very excited to introduce our newest recruit Franziska Fischer who joined our Stockholm office today.
Following the completion of her Masters at Karolinska Institutet Franziska has spent a year as […]
Earlier this year, Quantify Research became an officially recognised research entity in Norway by the European Commission‘s Eurostat, allowing us to access data provided by Statistics Norway (SSB, Statistisk sentralbyrå).
These […]
It’s a wrap on day two at Ispor! The Quantify Research team once again had the pleasure to meet many friends, new and old, and present a variety of research. We’re looking forward to […]
What a great first day at ISPOR! It was a busy Monday at booth C4-096 and we are looking forward to meeting many more of you today as we kick off day 2 at Ispor!
(For Danish, scroll down ?) We are thrilled to announce that Quantify Research has partnered with Niels Christian Hirsch, who will act as a Senior Advisor to Quantify’s Nordic and Danish […]
This week, we are thrilled to introduce our newest team member, Fredrika Juhlin, who joins us as an HR Generalist. Fredrika comes to us with a strong background as an HR Consultant and an impressive tenure in London, […]
To peck someone…again! Luckily in this case, the world of medical coding has us covered with the (hopefully) rare yet precise ICD code W61.32XD “Struck by a chicken, subsequent encounter.”
Although this rare event has a diagnosis code, not all diseases […]
Data that’s not fit-for-purpose can be scary, but here’s the good news – Nordic data has many characteristics that allow it to be considered high-quality for a wide range of purposes. These include:
✔️ Complete population coverage for administrative (claims-type) data
✔️ […]
In the pharmaceutical industry, evidence reviews are crucial for various activities such as HTA & reimbursement, regulatory submissions, RWE strategic planning, evidence gap identification, and GVD development.
Leverage the expertise of our Evidence Review & Synthesis team to determine the most […]
Check out the latest issue of PharmaTimes Magazine, where our CEO Kirk Geale explains how global pharmaceutical executives can harness the power of Nordic health data.
Nordic RWD are globally unique and practitioners should not miss the opportunities available […]